More than three dozen one-hour sessions offer the opportunity to discuss clinical case studies with world-renowned experts in a small-group setting. Adam Kilian, MD, FACP, FACR, explains how each of these add-on sessions explores a particular rheumatic disease, including individualized, evidence-based treatment plans.